{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Lung+Cancer+Prevention&page=2", "query": { "condition": "Lung Cancer Prevention", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Lung+Cancer+Prevention&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-29T13:37:21.554Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02237183", "title": "Iloprost in Preventing Lung Cancer in Former Smokers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Lung Carcinoma" ], "interventions": [ { "name": "Iloprost", "type": "DRUG" }, { "name": "Placebo Administration", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 34, "start_date": "2015-11-05", "completion_date": "2023-08-30", "has_results": false, "last_update_posted_date": "2023-11-28", "last_synced_at": "2026-09-29T13:37:21.554Z", "location_count": 2, "location_summary": "Aurora, Colorado • Denver, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02237183" }, { "nct_id": "NCT01446874", "title": "Prevention of Post-operative Pneumonia (POPP)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Post-operative Pneumonia", "Lung Cancer", "Esophageal Cancer" ], "interventions": [ { "name": "0.12% chlorhexidine solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2011-09-22", "completion_date": "2015-12-13", "has_results": true, "last_update_posted_date": "2018-11-08", "last_synced_at": "2026-09-29T13:37:21.554Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01446874" }, { "nct_id": "NCT06462365", "title": "Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hematologic Malignancy", "GvHD", "GVHD,Acute", "GVHD, Chronic", "Hematopoietic Stem Cell Transplant", "Acute Lymphoblastic Leukemia, Adult B-Cell", "Acute Lymphoblastic Leukemia, Adult T-Cell", "Acute Myeloid Leukemia in Remission", "Myelodysplastic Syndromes", "Chronic Myelomonocytic Leukemia, in Remission", "Cancer Remission" ], "interventions": [ { "name": "TRX103", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Tr1X, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2024-04-08", "completion_date": "2027-04-15", "has_results": false, "last_update_posted_date": "2025-04-15", "last_synced_at": "2026-09-29T13:37:21.554Z", "location_count": 5, "location_summary": "Duarte, California • Boston, Massachusetts • Minneapolis, Minnesota + 2 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "New York", "state": "New York" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT06462365" }, { "nct_id": "NCT00509444", "title": "Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Cancer", "Colon Cancer", "Rectum Cancer", "Cervix Cancer", "Prostate Cancer", "Lung Cancer" ], "interventions": [ { "name": "Educational materials", "type": "BEHAVIORAL" }, { "name": "educational materials, plus patient navigation", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Johns Hopkins Bloomberg School of Public Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 200, "start_date": "2006-10", "completion_date": "2010-12", "has_results": false, "last_update_posted_date": "2017-04-20", "last_synced_at": "2026-09-29T13:37:21.554Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00509444" }, { "nct_id": "NCT07410117", "title": "REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cancer-Associated Thrombosis (CAT)" ], "interventions": [ { "name": "REGN7508", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1120, "start_date": "2026-03-09", "completion_date": "2030-05-06", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-09-29T13:37:21.554Z", "location_count": 4, "location_summary": "Hialeah, Florida • North Miami Beach, Florida • New York, New York + 1 more", "locations": [ { "city": "Hialeah", "state": "Florida" }, { "city": "North Miami Beach", "state": "Florida" }, { "city": "New York", "state": "New York" }, { "city": "El Paso", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07410117" }, { "nct_id": "NCT05123118", "title": "Lung and Breast Cancer Prevention by an Integrated Intervention of Maternal Smoking Cessation and Breastfeeding", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Smoking, Cigarette", "Breastfeeding" ], "interventions": [ { "name": "Integrated intervention of smoking cessation and breastfeeding", "type": "BEHAVIORAL" }, { "name": "Attention placebo control", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Xiaozhong Wen", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 40, "start_date": "2021-01-01", "completion_date": "2023-10-30", "has_results": true, "last_update_posted_date": "2025-04-17", "last_synced_at": "2026-09-29T13:37:21.554Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05123118" }, { "nct_id": "NCT00453661", "title": "Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer", "Cervical Cancer", "Prostate Cancer", "Colorectal Cancer", "Lung Cancer" ], "interventions": [ { "name": "Questionnaire", "type": "BEHAVIORAL" }, { "name": "Patient Navigator (PN)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 2472, "start_date": "2007-03", "completion_date": "2020-09-28", "has_results": false, "last_update_posted_date": "2020-10-29", "last_synced_at": "2026-09-29T13:37:21.554Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00453661" }, { "nct_id": "NCT01451853", "title": "SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lung Cancer", "Head and Neck Cancer", "Hearing Loss", "Ototoxicity", "Tinnitus", "Neuropathy" ], "interventions": [ { "name": "SPI-1005 Low Dose", "type": "DRUG" }, { "name": "SPI-1005 Middle Dose", "type": "DRUG" }, { "name": "SPI-1005 High Dose", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sound Pharmaceuticals, Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "19 Years to 80 Years" }, "enrollment_count": 0, "start_date": "2026-06", "completion_date": "2026-06", "has_results": false, "last_update_posted_date": "2026-06-03", "last_synced_at": "2026-09-29T13:37:21.554Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01451853" }, { "nct_id": "NCT05120869", "title": "Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Health Personnel Attitude", "Health Knowledge, Attitudes, Practice" ], "interventions": [ { "name": "Tailored HPV Education and Professional Skills Intervention Group", "type": "BEHAVIORAL" }, { "name": "General HPV Education and Communication Skills Control Group", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Texas, El Paso", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 161, "start_date": "2023-12-22", "completion_date": "2024-12-02", "has_results": true, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-09-29T13:37:21.554Z", "location_count": 2, "location_summary": "Las Cruces, New Mexico • El Paso, Texas", "locations": [ { "city": "Las Cruces", "state": "New Mexico" }, { "city": "El Paso", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05120869" }, { "nct_id": "NCT07357597", "title": "An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Stomatitis" ], "interventions": [ { "name": "Dexamethasone mouthwash", "type": "DRUG" }, { "name": "Datopotamab Deruxtecan (Dato-DXd)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2026-06-24", "completion_date": "2028-01-04", "has_results": false, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-09-29T13:37:21.554Z", "location_count": 39, "location_summary": "Tucson, Arizona • Hot Springs, Arkansas • Little Rock, Arkansas + 35 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Duarte", "state": "California" }, { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07357597" } ] }